Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myeloma
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2023-12-01
|
| Series: | Blood Cancer Journal |
| Online Access: | https://doi.org/10.1038/s41408-023-00957-w |
| _version_ | 1827581815692460032 |
|---|---|
| author | Charalampos Charalampous Utkarsh Goel Prashant Kapoor Moritz Binder Francis K. Buadi Joselle Cook David Dingli Angela Dispenzieri Amie L. Fonder Morie A. Gertz Wilson Gonsalves Suzanne R. Hayman Miriam A. Hobbs Yi L. Hwa Taxiarchis Kourelis Martha Q. Lacy Nelson Leung Yi Lin Rahma Warsame Robert A. Kyle S. Vincent Rajkumar Shaji K. Kumar |
| author_facet | Charalampos Charalampous Utkarsh Goel Prashant Kapoor Moritz Binder Francis K. Buadi Joselle Cook David Dingli Angela Dispenzieri Amie L. Fonder Morie A. Gertz Wilson Gonsalves Suzanne R. Hayman Miriam A. Hobbs Yi L. Hwa Taxiarchis Kourelis Martha Q. Lacy Nelson Leung Yi Lin Rahma Warsame Robert A. Kyle S. Vincent Rajkumar Shaji K. Kumar |
| author_sort | Charalampos Charalampous |
| collection | DOAJ |
| first_indexed | 2024-03-08T22:41:45Z |
| format | Article |
| id | doaj.art-c837461b72b04beb8b1245eafa6f612b |
| institution | Directory Open Access Journal |
| issn | 2044-5385 |
| language | English |
| last_indexed | 2024-03-08T22:41:45Z |
| publishDate | 2023-12-01 |
| publisher | Nature Publishing Group |
| record_format | Article |
| series | Blood Cancer Journal |
| spelling | doaj.art-c837461b72b04beb8b1245eafa6f612b2023-12-17T12:07:31ZengNature Publishing GroupBlood Cancer Journal2044-53852023-12-011311410.1038/s41408-023-00957-wComparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myelomaCharalampos Charalampous0Utkarsh Goel1Prashant Kapoor2Moritz Binder3Francis K. Buadi4Joselle Cook5David Dingli6Angela Dispenzieri7Amie L. Fonder8Morie A. Gertz9Wilson Gonsalves10Suzanne R. Hayman11Miriam A. Hobbs12Yi L. Hwa13Taxiarchis Kourelis14Martha Q. Lacy15Nelson Leung16Yi Lin17Rahma Warsame18Robert A. Kyle19S. Vincent Rajkumar20Shaji K. Kumar21Division of Hematology, Department of Internal Medicine, Mayo ClinicDivision of Hematology, Department of Internal Medicine, Mayo ClinicDivision of Hematology, Department of Internal Medicine, Mayo ClinicDivision of Hematology, Department of Internal Medicine, Mayo ClinicDivision of Hematology, Department of Internal Medicine, Mayo ClinicDivision of Hematology, Department of Internal Medicine, Mayo ClinicDivision of Hematology, Department of Internal Medicine, Mayo ClinicDivision of Hematology, Department of Internal Medicine, Mayo ClinicDivision of Hematology, Department of Internal Medicine, Mayo ClinicDivision of Hematology, Department of Internal Medicine, Mayo ClinicDivision of Hematology, Department of Internal Medicine, Mayo ClinicDivision of Hematology, Department of Internal Medicine, Mayo ClinicDivision of Hematology, Department of Internal Medicine, Mayo ClinicDivision of Hematology, Department of Internal Medicine, Mayo ClinicDivision of Hematology, Department of Internal Medicine, Mayo ClinicDivision of Hematology, Department of Internal Medicine, Mayo ClinicDivision of Nephrology and Hypertension, Department of Internal Medicine, Mayo ClinicDivision of Hematology, Department of Internal Medicine, Mayo ClinicDivision of Hematology, Department of Internal Medicine, Mayo ClinicDivision of Hematology, Department of Internal Medicine, Mayo ClinicDivision of Hematology, Department of Internal Medicine, Mayo ClinicDivision of Hematology, Department of Internal Medicine, Mayo Clinichttps://doi.org/10.1038/s41408-023-00957-w |
| spellingShingle | Charalampos Charalampous Utkarsh Goel Prashant Kapoor Moritz Binder Francis K. Buadi Joselle Cook David Dingli Angela Dispenzieri Amie L. Fonder Morie A. Gertz Wilson Gonsalves Suzanne R. Hayman Miriam A. Hobbs Yi L. Hwa Taxiarchis Kourelis Martha Q. Lacy Nelson Leung Yi Lin Rahma Warsame Robert A. Kyle S. Vincent Rajkumar Shaji K. Kumar Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myeloma Blood Cancer Journal |
| title | Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myeloma |
| title_full | Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myeloma |
| title_fullStr | Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myeloma |
| title_full_unstemmed | Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myeloma |
| title_short | Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myeloma |
| title_sort | comparison of daratumumab based regimens as second line therapy in relapsed refractory multiple myeloma |
| url | https://doi.org/10.1038/s41408-023-00957-w |
| work_keys_str_mv | AT charalamposcharalampous comparisonofdaratumumabbasedregimensassecondlinetherapyinrelapsedrefractorymultiplemyeloma AT utkarshgoel comparisonofdaratumumabbasedregimensassecondlinetherapyinrelapsedrefractorymultiplemyeloma AT prashantkapoor comparisonofdaratumumabbasedregimensassecondlinetherapyinrelapsedrefractorymultiplemyeloma AT moritzbinder comparisonofdaratumumabbasedregimensassecondlinetherapyinrelapsedrefractorymultiplemyeloma AT franciskbuadi comparisonofdaratumumabbasedregimensassecondlinetherapyinrelapsedrefractorymultiplemyeloma AT josellecook comparisonofdaratumumabbasedregimensassecondlinetherapyinrelapsedrefractorymultiplemyeloma AT daviddingli comparisonofdaratumumabbasedregimensassecondlinetherapyinrelapsedrefractorymultiplemyeloma AT angeladispenzieri comparisonofdaratumumabbasedregimensassecondlinetherapyinrelapsedrefractorymultiplemyeloma AT amielfonder comparisonofdaratumumabbasedregimensassecondlinetherapyinrelapsedrefractorymultiplemyeloma AT morieagertz comparisonofdaratumumabbasedregimensassecondlinetherapyinrelapsedrefractorymultiplemyeloma AT wilsongonsalves comparisonofdaratumumabbasedregimensassecondlinetherapyinrelapsedrefractorymultiplemyeloma AT suzannerhayman comparisonofdaratumumabbasedregimensassecondlinetherapyinrelapsedrefractorymultiplemyeloma AT miriamahobbs comparisonofdaratumumabbasedregimensassecondlinetherapyinrelapsedrefractorymultiplemyeloma AT yilhwa comparisonofdaratumumabbasedregimensassecondlinetherapyinrelapsedrefractorymultiplemyeloma AT taxiarchiskourelis comparisonofdaratumumabbasedregimensassecondlinetherapyinrelapsedrefractorymultiplemyeloma AT marthaqlacy comparisonofdaratumumabbasedregimensassecondlinetherapyinrelapsedrefractorymultiplemyeloma AT nelsonleung comparisonofdaratumumabbasedregimensassecondlinetherapyinrelapsedrefractorymultiplemyeloma AT yilin comparisonofdaratumumabbasedregimensassecondlinetherapyinrelapsedrefractorymultiplemyeloma AT rahmawarsame comparisonofdaratumumabbasedregimensassecondlinetherapyinrelapsedrefractorymultiplemyeloma AT robertakyle comparisonofdaratumumabbasedregimensassecondlinetherapyinrelapsedrefractorymultiplemyeloma AT svincentrajkumar comparisonofdaratumumabbasedregimensassecondlinetherapyinrelapsedrefractorymultiplemyeloma AT shajikkumar comparisonofdaratumumabbasedregimensassecondlinetherapyinrelapsedrefractorymultiplemyeloma |